Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The process of inducing immune tolerance to allergens from *Dermatophagoides pteronyssinus* (house dust mite) through repeated exposure. This involves complex cellular and molecular mechanisms that shift the immune response from an allergic (Th2-dominated) profile toward a tolerant state characterized by regulatory T cell induction, anti-inflammatory cytokine production, and antibody class switching.
Induction and expansion of allergen-specific regulatory T cells (Tregs), increased production of immunosuppressive cytokines (IL-10, TGF-β), antibody class switching to IgG4, and modulation of dendritic cell function to promote tolerance.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Induction of Immune Tolerance via Repeated Exposure to Dermatophagoides pteronyssinus Allergens.